Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional profiling

Drug Resistance Updates

Volumn 17, Issue 3, 2014, Pages 64-76

  Zeng, Tao ^a   Wang, Diane Catherine ^b   Wang, Xiangdong ^c   Xu, Feng ^d   Chen, Luonan ^a,e  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^c FUDAN UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e INSTITUTE OF INDUSTRIAL SCIENCE   (Japan)

Author keywords

Bioinformatics; Drug sensitivity; Network; Resistance; Systems biology

Indexed keywords

INTERFERON; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2B; RIBAVIRIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

ACCURACY; ANTIVIRAL THERAPY; ARTICLE; DRUG EFFICACY; DRUG RESISTANCE; DRUG RESPONSE; DRUG SENSITIVITY; GENE EXPRESSION; GENOTYPE; HEPATITIS C; MATHEMATICAL MODEL; MODULE NETWORK REWIRING ANALYSIS; PHARMACOGENOMICS; SPATIOTEMPORAL ANALYSIS; TREATMENT RESPONSE; ANTIBIOTIC RESISTANCE; BIOLOGICAL MODEL; BIOTRANSFORMATION; DRUG EFFECTS; DRUG HYPERSENSITIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; INFECTION; METABOLISM; MICROBIOLOGY; PHARMACOGENETICS; PROCEDURES; SYSTEMS BIOLOGY; TRENDS;

ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; BIOTRANSFORMATION; DRUG HYPERSENSITIVITY; DRUG RESISTANCE, MICROBIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFECTION; MODELS, BIOLOGICAL; PHARMACOGENETICS; SYSTEMS BIOLOGY;

EID: 84909578095     PISSN: 13687646     EISSN: 15322084     Source Type: Journal    
DOI: 10.1016/j.drup.2014.08.002     Document Type: Article

References (75)

1. Alsford, S., Eckert, S., Baker, N., Glover, L., Sanchez-Flores, A., Leung, K.F., Turner, D. Field, M.C., Berriman, M., Horn, D., 2012. High-throughput decoding of antitrypanosomal drug efficacy and resistance. Nature 482 (7384), 232-236.
2. Archer, K.J., Mas, V.R., David, K., Maluf, D.G., Bornstein, K., Fisher, R.A., 2009. Identifying genes for establishing a multigenic test for hepatocellular carcinoma surveillance in hepatitis C virus-positive cirrhotic patients. Cancer Epidemiol. Biomarkers Prev. 18 (11), 2929-2932.
3. Azuaje, F., Devaux, Y., Wagner, D.R., 2010. Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network. BMC Syst. Biol. 4, 60.
4. Bandyopadhyay, S., Mehta, M., Kuo, D., Sung, M.K., Chuang, R., Jaehnig, E.J., Bodenmiller, B., Licon, K., Copeland, W., Shales, M., et al., 2010. Rewiring of genetic networks in response to DNA damage. Science 330 (6009), 1385-1389.
5. Barabasi, A.L., Oltvai, Z.N., 2004. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 5 (2), 101-113.
6. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A., Kim, S., Wilson, C.J., Lehar, J., Kryukov, G.V., Sonkin, D., et al., 2012. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483 (7391), 603-607.
7. Beltrao, P., Cagney, G., Krogan, N.J., 2010. Quantitative genetic interactions reveal biological modularity. Cell 141 (5), 739-745.
8. Beyer, A., Bandyopadhyay, S., Ideker, T., 2007. Integrating physical and genetic maps: from genomes to interaction networks. Nat. Rev. Genet. 8 (9), 699-710.
9. Bhardwaj, N., Kim, P.M., Gerstein, M.B., 2010. Rewiring of transcriptional regulatory networks: hierarchy, rather than connectivity, better reflects the importance regulators. Sci. Signal 3 (146), ra79.
10. Breitkreutz, D., Hlatky, L., Rietman, E., Tuszynski, J.A., 2012. Molecular signaling network complexity is correlated with cancer patient survivability. Proc. Natl. Acad. Sci. U. S. A. 109 (23), 9209-9212.
11. Caraux, G., Pinloche, S., 2005. PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics 21 1280-1281.
12. Chan, E., Prado, D.E., Weidhaas, J.B., 2011. Cancer microRNAs: from subtype profiling to predictors of response to therapy. Trends Mol. Med. 17 (5), 235-243.
13. Chen, B.J., Causton, H.C., Mancenido, D., Goddard, N.L., Perlstein, E.O., Pe'er, D., 2009. Harnessing gene expression to identify the genetic basis of drug resistance. Mol. Syst. Biol. 5, 310.
14. Chen, L., Liu, R., Liu, Z.P., Li, M., Aihara, K., 2012. Detecting early-warning signals sudden deterioration of complex diseases by dynamical network biomarkers. Sci. Rep. 2, 342.
15. Ching, Y.P., Leong, V.Y., Lee, M.F., Xu, H.T., Jin, D.Y., Ng, I.O., 2007. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation. Cancer Res. 67 (8), 3601-3608.
16. Cohen, A.L., Soldi, R., Zhang, H., Gustafson, A.M., Wilcox, R., Welm, B.E., Chang, Johnson, E., Spira, A., Jeffrey, S.S., et al., 2011. A pharmacogenomic method individualized prediction of drug sensitivity. Mol. Syst. Biol. 7, 513.
17. De Smet, R., Van de Peer, Y., 2012. Redundancy and rewiring of genetic networks following genome-wide duplication events. Curr. Opin. Plant Biol. 15 168-176.
18. Duffy, M.J., O'Donovan, N., Crown, J., 2011. Use of molecular markers for predicting therapy response in cancer patients. Cancer Treat. Rev. 37 (2), 151-159.
19. Farci, P., Strazzera, R., Alter, H.J., Farci, S., Degioannis, D., Coiana, A., Peddis, G., Usai, F., Serra, G., Chessa, L., et al., 2002. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc. Natl. Acad. U. S. A. 99 (5), 3081-3086.
20. Freschi, L., Courcelles, M., Thibault, P., Michnick, S.W., Landry, C.R., 2011. Phosphorylation network rewiring by gene duplication. Mol. Syst. Biol. 7, 504.
21. Hall, M., Frank, E., Holmes, G., Pfahringer, B., Reutemann, P., Witten, I.H., 2009. The WEKA data mining software: an update. SIGKDD Explor Newsl. 11 (1), 10-18.
22. Han, J., Cheng, H., Xin, D., Yan, X., 2007. Frequent pattern mining: current status and future directions. Data Min Knowl. Discov. 15 (1), 55-86.
23. He, B., Qiu, X., Li, P., Wang, L., Lv, Q., Shi, T., 2010. HCCNet: an integrated network database of hepatocellular carcinoma. Cell Res. 20 (6), 732-734.
24. He, D., Liu, Z.P., Honda, M., Kaneko, S., Chen, L., 2012. Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. J. Mol. Cell Biol. 4 (3), 140-152.
25. Herschkowitz, J.I., Simin, K., Weigman, V.J., Mikaelian, I., Usary, J., Hu, Z., Rasmussen, K.E., Jones, L.P., Assefnia, S., Chandrasekharan, S., et al., 2007. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8 (5), R76.
26. Honda, M., Nakamura, M., Tateno, M., Sakai, A., Shimakami, T., Shirasaki, Yamashita, T., Arai, K., Sakai, Y., Kaneko, S., 2010. Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C. Hepatol. 53 (5), 817-826.
27. Hoppe, R., Brauch, H., Kroetz, D.L., Esteller, M., 2011. Exploiting the complexity the genome and transcriptome using pharmacogenomics towards personalized medicine. Genome Biol. 12 (1), 301.
28. Hou, L., Wang, L., Qian, M., Li, D., Tang, C., Zhu, Y., Deng, M., Li, F., 2011. Modular analysis of the probabilistic genetic interaction network. Bioinformatics 27 853-859.
29. Huang, T., Tu, K., Shyr, Y., Wei, C.C., Xie, L., Li, Y.X., 2008. The prediction of interferon treatment effects based on time series microarray gene expression profiles. Transl. Med. 6, 44.
30. Ihmels, J., Friedlander, G., Bergmann, S., Sarig, O., Ziv, Y., Barkai, N., 2002. Revealing modular organization in the yeast transcriptional network. Nat. Genet. 31 (4), 370-377.
31. Ihmels, J., Bergmann, S., Gerami-Nejad, M., Yanai, I., McClellan, M., Berman, J., Barkai, N., 2005. Rewiring of the yeast transcriptional network through the evolution of motif usage. Science 309 (5736), 938-940.
32. Ishida, H., Li, K., Yi, M., Lemon, S.M., 2007. p21-activated kinase 1 is activated through the mammalian target of rapamycin/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells. J. Biol. Chem. 282 (16), 11836-11848.
33. Jaimovich, A., Rinott, R., Schuldiner, M., Margalit, H., Friedman, N., 2010. Modularity and directionality in genetic interaction maps. Bioinformatics 26 (12), i228-i236.
34. Jiang, C., Xuan, Z., Zhao, F., Zhang, M.Q., 2007. TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res. 35 (Database issue), D137-D140.
35. Kariko, K., Muramatsu, H., Ludwig, J., Weissman, D., 2011. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 39 (21), e142.
36. Komurov, K., White, M., 2007. Revealing static and dynamic modular architecture of the eukaryotic protein interaction network. Mol. Syst. Biol. 3, 110.
37. Kovacs, I.A., Palotai, R., Szalay, M.S., Csermely, P., 2010. Community landscapes: an integrative approach to determine overlapping network module hierarchy, identify key nodes and predict network dynamics. PLoS One 5 (9).
38. Langfelder, P., Luo, R., Oldham, M.C., Horvath, S., 2011. Is my network module preserved and reproducible? PLoS Comput. Biol. 7 (1), e1001057.
39. Li, M., Zeng, T., Liu, R., Chen, L., 2013. Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. Brief. Bioinform., http://dx.doi.org/10.1093/bib/bbt1027.
40. Liu, C., Li, J., Zhao, Y., 2010. Exploring hierarchical and overlapping modular structure in the yeast protein interaction network. BMC Genomics 11 (Suppl4), S17.
41. Liu, X., Liu, Z.P., Zhao, X.M., Chen, L., 2012. Identifying disease genes and module biomarkers by differential interactions. J. Am. Med. Inform. Assoc. 19 (2), 241-248.
42. Liu, R., Wang, X., Aihara, K., Chen, L., 2013. Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers. Med. Res. Rev., http://dx.doi.org/10.1002/med.21293.
43. Lord, C.J., Ashworth, A., 2012. The DNA damage response and cancer therapy. Nature 481 (7381), 287-294.
44. Lu, Y.S., Kashida, Y., Kulp, S.K., Wang, Y.C., Wang, D., Hung, J.H., Tang, M., Lin, Z.Z., Chen, T.J., Cheng, A.L., et al., 2007. Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma. Hepatology 46 (4), 1119-1130.
45. Luscombe, N.M., Babu, M.M., Yu, H., Snyder, M., Teichmann, S.A., Gerstein, M., 2004. Genomic analysis of regulatory network dynamics reveals large topological changes. Nature 431 (7006), 308-312.
46. Lussier, Y.A., Li, H., 2012. The rise of translational bioinformatics. Genome Biol. 13 (8), 319.
47. Miura, K., Taura, K., Kodama, Y., Schnabl, B., Brenner, D.A., 2008. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 48 (5), 1420-1429.
48. Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., Kanehisa, M., 1999. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 27 (1), 29-34.
49. Ottaviani, D., Lever, E., Mao, S., Christova, R., Ogunkolade, B.W., Jones, T.A., Szary, J., Aarum, J., Mumin, M.A., Pieri, C.A., et al., 2012. CTCF binds to sites in the major histocompatibility complex that are rapidly reconfigured in response to interferon-gamma. Nucleic Acids Res. 40 (12), 5262-5270.
50. Powell, S.N., Bindra, R.S., 2009. Targeting the DNA damage response for cancer therapy. DNA Repair (Amst) 8 (9), 1153-1165.
51. Razick, S., Magklaras, G., Donaldson, I.M., 2008. iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinform. 9, 405.
52. Reimand, J., Kull, M., Peterson, H., Hansen, J., Vilo, J., 2007. g:Profiler - a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 35 (Web Server issue), W193-W200.
53. Roguev, A., Bandyopadhyay, S., Zofall, M., Zhang, K., Fischer, T., Collins, S.R., Qu, H., Shales, M., Park, H.O., Hayles, J., et al., 2008. Conservation and rewiring offunctional modules revealed by an epistasis map in fission yeast. Science 322 (5900), 405-410.
54. Sarasin-Filipowicz, M., Oakeley, E.J., Duong, F.H., Christen, V., Terracciano, L., Filipowicz, W., Heim, M.H., 2008. Interferon signaling and treatment outcome in chronic hepatitis C. Proc. Natl. Acad. Sci. U. S. A. 105 (19), 7034-7039.
55. Shou, C., Bhardwaj, N., Lam, H.Y., Yan, K.K., Kim, P.M., Snyder, M., Gerstein, M.B., 2011. Measuring the evolutionary rewiring of biological networks. PLoS Comput. Biol. 7 (1), e1001050.
56. Sim, S.C., Ingelman-Sundberg, M., 2011. Pharmacogenomic biomarkers: new tools in current and future drug therapy. Trends Pharmacol. Sci. 32 (2), 72-81.
57. Sinha, R., Shaham, Y., Heilig, M., 2011. Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology (Berl) 218 (1), 69-82.
58. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., et al., 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102 (43), 15545-15550.
59. Sun, M.G., Sikora, M., Costanzo, M., Boone, C., Kim, P.M., 2012. Network evolution: rewiring and signatures of conservation in signaling. PLoS Comput. Biol. 8 (3), e1002411.
60. Tatebe, K., Zeytun, A., Ribeiro, R.M., Hoffmann, R., Harrod, K.S., Forst, C.V., 2010. Response network analysis of differential gene expression in human epithelial lung cells during avian influenza infections. BMC Bioinform. 11, 170.
61. Taylor, M.W., Tsukahara, T., Brodsky, L., Schaley, J., Sanda, C., Stephens, M. McClintick, J.N., Edenberg, H.J., Li, L., Tavis, J.E., et al., 2007. Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. Virol. 81 (7), 3391-3401.
62. Taylor, M.W., Tsukahara, T., McClintick, J.N., Edenberg, H.J., Kwo, P., 2008. Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment. J. Transl. Med. 6, 66.
63. Torkamani, A., Schork, N.J., 2012. Background gene expression networks significantly enhance drug response prediction by transcriptional profiling. Pharmacogenomics J. 12 (5), 446-452.
64. Vassilev, L.T., 2007. MDM2 inhibitors for cancer therapy. Trends Mol. Med. 13 (1), 23-31.
65. Vaughan, L., 2001. Statistical Methods for the Information Professional. Information Today, Inc, Medford, NJ, USA.
66. Wang, J., Huang, Q., Liu, Z.P., Wang, Y., Wu, L.Y., Chen, L., Zhang, X.S., 2011. NOA: novel Network Ontology Analysis method. Nucleic Acids Res. 39 (13), e87.
67. Wang, Y., Xu, M., Wang, Z., Tao, M., Zhu, J., Wang, L., Li, R., Berceli, S.A., Wu, R., 2012. How to cluster gene expression dynamics in response to environmental signals. Brief. Bioinform. 13 (2), 162-174.
68. Welch, W.J., 1992. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol. Rev. 72 (4), 1063-1081.
69. Yu, X., Li, G., Chen, L., 2013. Prediction and early diagnosis of complex diseases by edge-network. Bioinformatics, http://dx.doi.org/10.1093/bioinformatics/btt620.
70. Yuasa, T., Takahashi, S., Hatake, K., Yonese, J., Fukui, I., 2011. Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer. Cancer Sci. 102 (11), 1949-1957.
71. Zeng, T., Chen, L., 2012. Tracing dynamic biological processes during phase transition. BMC Syst. Biol. 6 (Suppl. 1), S12.
72. Zeng, T., Sun, S.Y., Wang, Y., Zhu, H., Chen, L., 2013. Network biomarkers reveal dysfunctional gene regulations during disease progression. FEBS J. 280 (22), 5682-5695.
73. Zeng, T., Zhang, C.C., Zhang, W., Liu, R., Liu, J., Chen, L., 2014. Deciphering early development of complex diseases by progressive module network. Methods 67 (3), 334-343.
74. Zhang, W., Zeng, T., Chen, L., 2014. EdgeMarker: identifying differentially correlated molecule pairs as edge-biomarkers. J. Theor. Biol., http://dx.doi.org/10.1016/j.jtbi.2014.05.041.
75. Zheng, G., Tu, K., Yang, Q., Xiong, Y., Wei, C., Xie, L., Zhu, Y., Li, Y., 2008. ITFP: an integrated platform of mammalian transcription factors. Bioinformatics 24 (20), 2416-2417.